SCHEMBL2609898

SCHEMBL2609898

CC1(C)c2cc(-c3ccc4c(c3)C(C)(C)c3cc5c6ccccc6n(-c6ccc7c(c6)C(C)(C)c6cc8c9ccccc9n(-c9ccccc9)c8cc6-7)c5cc3-4)ccc2-c2cc3c(cc21)c1ccccc1n3-c1ccc2c(c1)C(C)(C)c1cc3c4ccccc4n(-c4ccccc4)c3cc1-2

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ATM Q13315 1/20 0.44
HDAC4 P56524 1/20 0.36
KMT2A Q03164 2/20 0.31
MAPK8 P45983 1/20 0.31
IL1R1 P14778 1/20 0.31
RXRA P19793 1/20 0.30
RXRB P28702 1/20 0.30
PTGER4 P35408 1/20 0.30
MEN1 O00255 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MAPT P10636 1/20 0.30
HTT P42858 1/20 0.30
PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2609897 0.98 L3MBTL1 (0.42) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL16744953 0.96 KDM4E (0.43) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL2609845 0.96 L3MBTL1 (0.45) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL2609862 0.96 L3MBTL1 (0.47) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL2609863 0.95 L3MBTL1 (0.46) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12116350 0.95 KDM4E (0.49) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12116368 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12116365 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL2609838 0.94 KDM4E (0.45) L3MBTL1KDM4EATMHDAC4KMT2A
SCHEMBL12647527 0.94 L3MBTL1 (0.41) L3MBTL1KDM4EATMHDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9224961-B2 Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-29 US disclosed
US-9224961-B2 Condensed-cyclic compound, organic light-emitting diode comprising the same and flat panel display device comprising the organic light-emitting diode SAMSUNG DISPLAY CO., LTD. (KR) 2015-12-29 US disclosed
US-20120097932-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE SAMSUNG MOBILE DISPLAY CO., LTD. (KR) 2012-04-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120097932-A1 CONDENSED-CYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DIODE COMPRISING THE SAME AND FLAT PANEL DISPLAY DEVICE COMPRISING THE ORGANIC LIGHT-EMITTING DIODE OCIAD1, OCIAD2, CFD L3MBTL1 2477/4885KDM4E 3315/4885ATM 4310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.